Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
434
9.080
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
73
3.840
 Why?
Immunologic Factors
13
2025
229
2.640
 Why?
Neurology
10
2018
103
2.360
 Why?
Immunosuppressive Agents
10
2024
686
1.730
 Why?
Neuromyelitis Optica
4
2023
127
1.180
 Why?
Natalizumab
11
2021
40
0.970
 Why?
Recurrence
8
2025
1001
0.930
 Why?
Diagnostic Errors
2
2017
160
0.740
 Why?
Brain
16
2025
2618
0.720
 Why?
Internship and Residency
5
2011
1054
0.710
 Why?
Drug Substitution
2
2019
52
0.670
 Why?
Fingolimod Hydrochloride
5
2020
35
0.660
 Why?
Rituximab
4
2020
163
0.620
 Why?
Data Collection
4
2011
649
0.610
 Why?
Dementia, Vascular
3
2009
18
0.600
 Why?
Drug Monitoring
1
2019
184
0.580
 Why?
Early Medical Intervention
1
2017
58
0.540
 Why?
Magnetic Resonance Imaging
24
2025
3366
0.540
 Why?
Medication Adherence
2
2019
573
0.530
 Why?
Early Diagnosis
2
2017
236
0.530
 Why?
Humans
87
2025
128524
0.520
 Why?
Glatiramer Acetate
6
2019
18
0.520
 Why?
Calcinosis
2
2009
231
0.500
 Why?
Physicians
4
2016
860
0.500
 Why?
Postural Balance
3
2018
197
0.480
 Why?
Antibodies, Monoclonal, Humanized
8
2023
759
0.460
 Why?
Fatigue
3
2018
320
0.400
 Why?
Dimethyl Fumarate
3
2020
11
0.380
 Why?
Immunoglobulin G
4
2023
837
0.370
 Why?
Middle Aged
39
2025
30893
0.360
 Why?
Practice Guidelines as Topic
1
2018
1490
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
26
0.340
 Why?
Adult
43
2025
35315
0.340
 Why?
Withholding Treatment
2
2021
70
0.330
 Why?
Psychiatry
2
2009
173
0.310
 Why?
Cysts
1
2009
108
0.300
 Why?
Demyelinating Diseases
4
2019
82
0.300
 Why?
HIV Long Terminal Repeat
3
2001
10
0.300
 Why?
Education, Medical
1
2011
244
0.290
 Why?
Certification
1
2008
95
0.290
 Why?
Female
49
2025
68127
0.280
 Why?
Autoantibodies
3
2023
1463
0.280
 Why?
Lymphopenia
2
2020
59
0.280
 Why?
Education
2
2007
99
0.270
 Why?
Male
40
2025
62883
0.270
 Why?
Central Nervous System Cysts
1
2006
13
0.270
 Why?
Clinical Trials as Topic
3
2016
998
0.270
 Why?
Cerebral Arteries
1
2006
57
0.260
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
48
0.260
 Why?
Single-Blind Method
3
2023
269
0.260
 Why?
Cerebrovascular Disorders
1
2006
89
0.250
 Why?
Societies, Medical
4
2019
749
0.250
 Why?
DNA, Viral
2
1998
348
0.250
 Why?
Ethics, Medical
2
2015
78
0.240
 Why?
Treatment Outcome
12
2023
10163
0.240
 Why?
HIV Seropositivity
2
1998
119
0.240
 Why?
Databases, Factual
3
2016
1268
0.230
 Why?
Drug Industry
2
2016
106
0.230
 Why?
Double-Blind Method
4
2023
1860
0.220
 Why?
Conflict of Interest
2
2016
123
0.220
 Why?
AIDS Dementia Complex
3
2001
51
0.210
 Why?
Microglia
2
2024
227
0.210
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
59
0.200
 Why?
Heart Aneurysm
1
2002
10
0.200
 Why?
Quality of Health Care
2
2017
607
0.190
 Why?
Heart Septal Defects, Atrial
1
2002
46
0.190
 Why?
B-Lymphocytes
5
2023
820
0.190
 Why?
Lymphoma
2
2005
194
0.190
 Why?
Interferon beta-1a
2
2019
12
0.190
 Why?
Mental Disorders
2
2007
1007
0.180
 Why?
Neuroimaging
1
2023
275
0.180
 Why?
Brain Neoplasms
4
2016
1149
0.180
 Why?
Education, Medical, Continuing
2
2015
124
0.180
 Why?
Central Nervous System Neoplasms
2
2005
147
0.180
 Why?
Agammaglobulinemia
1
2020
33
0.170
 Why?
Interferon-gamma
1
2023
761
0.170
 Why?
Disease Progression
4
2021
2603
0.170
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Neutropenia
1
2020
136
0.160
 Why?
Indans
1
2019
10
0.160
 Why?
Oxadiazoles
1
2019
34
0.160
 Why?
Referral and Consultation
1
2005
727
0.160
 Why?
Diagnosis, Differential
4
2023
1416
0.160
 Why?
Adjuvants, Immunologic
3
2015
221
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.150
 Why?
Salvage Therapy
1
2019
137
0.150
 Why?
Educational Measurement
3
2015
261
0.150
 Why?
Herpesvirus 8, Human
1
1998
59
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
255
0.140
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
573
0.140
 Why?
Eye Movements
1
2018
58
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Young Adult
7
2024
12320
0.140
 Why?
Physician-Patient Relations
2
2016
530
0.140
 Why?
Patient Selection
2
2015
661
0.140
 Why?
Central Nervous System
2
2005
255
0.140
 Why?
Sarcoma, Kaposi
1
1998
76
0.140
 Why?
Herpesvirus 4, Human
1
2018
151
0.140
 Why?
Nervous System Diseases
2
2024
251
0.130
 Why?
Aged
9
2024
21971
0.130
 Why?
Herpesviridae Infections
1
1998
134
0.130
 Why?
Suicide, Assisted
1
1997
26
0.130
 Why?
Neurologists
1
2016
20
0.130
 Why?
Costs and Cost Analysis
1
2017
208
0.130
 Why?
Estriol
1
2015
7
0.130
 Why?
Cost-Benefit Analysis
2
2016
581
0.130
 Why?
Retrospective Studies
10
2024
14460
0.130
 Why?
Dizziness
2
2018
80
0.120
 Why?
Verbal Learning
2
2013
64
0.120
 Why?
Corpus Callosum
2
2006
66
0.120
 Why?
T-Lymphocytes
1
2023
1922
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
95
0.120
 Why?
Trust
1
2016
115
0.120
 Why?
Follow-Up Studies
6
2020
4898
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
50
0.110
 Why?
Exercise Therapy
1
2018
414
0.110
 Why?
Insurance, Health
1
2016
271
0.110
 Why?
Stroke
1
2002
1064
0.110
 Why?
Medication Reconciliation
1
2013
29
0.110
 Why?
CD40 Antigens
1
2014
88
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
136
0.110
 Why?
JC Virus
1
2013
23
0.100
 Why?
Anti-Inflammatory Agents
2
2006
469
0.100
 Why?
Population Surveillance
1
2016
427
0.100
 Why?
Sensation Disorders
1
2012
31
0.100
 Why?
Memory Disorders
1
2013
158
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
80
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
37
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
16
0.100
 Why?
HIV-1
2
2001
840
0.100
 Why?
Glioma
1
2016
352
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
410
0.090
 Why?
United States
8
2024
13876
0.090
 Why?
Gadolinium
4
2018
77
0.090
 Why?
Academies and Institutes
1
2011
48
0.090
 Why?
Self-Assessment
1
2011
69
0.090
 Why?
Learning
1
2015
390
0.090
 Why?
Nerve Regeneration
1
2010
62
0.090
 Why?
Fatal Outcome
3
2006
301
0.090
 Why?
Quality of Life
3
2021
2680
0.090
 Why?
Leukocytosis
1
2010
33
0.080
 Why?
Diagnostic Tests, Routine
1
2011
103
0.080
 Why?
Antigens, CD19
3
2007
114
0.080
 Why?
Biomarkers
3
2014
3881
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
19
0.080
 Why?
Exercise Test
1
2012
615
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Severity of Illness Index
3
2014
2736
0.080
 Why?
Disease Management
1
2013
588
0.080
 Why?
Guidelines as Topic
1
2011
260
0.080
 Why?
Spinal Cord
3
2023
354
0.080
 Why?
Neuroprotective Agents
1
2009
109
0.070
 Why?
Physical Therapy Modalities
1
2011
290
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1266
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Immunoglobulin Variable Region
2
2004
79
0.070
 Why?
Workload
1
2009
150
0.070
 Why?
Antibodies, Monoclonal
2
2011
1355
0.070
 Why?
Neuropsychological Tests
2
2013
1003
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
14
0.070
 Why?
CD4-Positive T-Lymphocytes
1
1993
1046
0.070
 Why?
Headache Disorders
1
2006
15
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
43
0.070
 Why?
Medical Records
1
2007
169
0.070
 Why?
Syndrome
2
2023
335
0.070
 Why?
Huntington Disease
1
2007
48
0.070
 Why?
Methylprednisolone
1
2006
82
0.070
 Why?
Contrast Media
3
2018
384
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
93
0.070
 Why?
International Classification of Diseases
1
2007
124
0.070
 Why?
Antibody Formation
1
2007
287
0.060
 Why?
Adolescent
8
2024
20213
0.060
 Why?
Herpes Zoster
1
2010
317
0.060
 Why?
Canada
2
2019
345
0.060
 Why?
Aquaporin 4
1
2006
95
0.060
 Why?
DNA Mutational Analysis
1
2006
386
0.060
 Why?
Fellowships and Scholarships
1
2009
273
0.060
 Why?
Health Care Surveys
1
2007
557
0.060
 Why?
RNA, Messenger
1
1992
2674
0.060
 Why?
Teaching
1
2007
209
0.060
 Why?
Patient Compliance
1
2009
562
0.060
 Why?
Surveys and Questionnaires
4
2016
5346
0.060
 Why?
Cognition Disorders
1
2009
496
0.060
 Why?
Neurologic Examination
1
2005
114
0.060
 Why?
Analysis of Variance
3
2015
1271
0.060
 Why?
Colorado
2
2024
4392
0.060
 Why?
Program Evaluation
1
2009
874
0.060
 Why?
Erythrocytes
1
2010
670
0.060
 Why?
Affect
1
2007
285
0.060
 Why?
Central Nervous System Diseases
1
2005
66
0.060
 Why?
Neutrophils
1
2010
1188
0.060
 Why?
Simvastatin
1
2004
55
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Prevalence
2
2024
2549
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
38
0.050
 Why?
Faculty, Medical
1
2006
265
0.050
 Why?
B-Lymphocyte Subsets
1
2003
75
0.050
 Why?
Neurodegenerative Diseases
1
2024
110
0.050
 Why?
Cyclophosphamide
1
2003
231
0.050
 Why?
Radiography
1
2005
864
0.050
 Why?
Academic Medical Centers
1
2005
473
0.050
 Why?
Anticoagulants
1
2006
613
0.050
 Why?
Single-Cell Analysis
1
2024
274
0.050
 Why?
Students, Medical
1
2006
314
0.050
 Why?
Infusions, Intravenous
1
2023
384
0.050
 Why?
Patient Outcome Assessment
1
2023
127
0.050
 Why?
Membrane Glycoproteins
1
2004
466
0.050
 Why?
Induced Pluripotent Stem Cells
1
2024
223
0.050
 Why?
Lymphoma, B-Cell
2
2005
104
0.050
 Why?
Cross-Sectional Studies
1
2012
5040
0.050
 Why?
Dementia
1
2005
227
0.050
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.050
 Why?
Peptides
3
2013
909
0.050
 Why?
Schools, Medical
1
2002
130
0.050
 Why?
Pain
1
2007
756
0.050
 Why?
Time Factors
4
2018
6503
0.050
 Why?
Disability Evaluation
2
2014
289
0.050
 Why?
Molecular Sequence Data
3
2004
2818
0.050
 Why?
Clinical Competence
1
2008
1014
0.050
 Why?
Antibodies, Antinuclear
1
2001
65
0.040
 Why?
Atrophy
1
2021
172
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
145
0.040
 Why?
Venous Thrombosis
1
2002
158
0.040
 Why?
Consensus
1
2023
633
0.040
 Why?
Mobility Limitation
1
2020
62
0.040
 Why?
Child
5
2016
20721
0.040
 Why?
Interferon-beta
2
2011
87
0.040
 Why?
Antibodies, Viral
1
2023
593
0.040
 Why?
Lipids
1
2023
624
0.040
 Why?
Lymphocyte Activation
1
2003
1098
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
70
0.040
 Why?
Cerebral Infarction
1
1998
41
0.040
 Why?
Cell Separation
2
2014
313
0.040
 Why?
HIV Seronegativity
1
1998
25
0.040
 Why?
Transplantation, Autologous
1
2019
215
0.040
 Why?
Genes, myc
1
1998
50
0.040
 Why?
Base Sequence
2
2001
2134
0.040
 Why?
Astrocytoma
1
1998
120
0.040
 Why?
In Situ Hybridization
1
2018
292
0.040
 Why?
Gene Library
1
1997
116
0.030
 Why?
Risk Assessment
1
2006
3256
0.030
 Why?
Gene Rearrangement
1
1998
145
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
326
0.030
 Why?
Syndecan-1
2
2007
27
0.030
 Why?
Breast Neoplasms
1
2008
2139
0.030
 Why?
Morals
1
1997
73
0.030
 Why?
Managed Care Programs
1
1997
133
0.030
 Why?
Drug Administration Schedule
1
2018
757
0.030
 Why?
Risk Factors
3
2008
9727
0.030
 Why?
Viral Load
1
2018
450
0.030
 Why?
Flow Cytometry
2
2014
1141
0.030
 Why?
Mutation
1
2006
3692
0.030
 Why?
Polymerase Chain Reaction
1
1998
1019
0.030
 Why?
Survival Analysis
1
2018
1265
0.030
 Why?
Sequence Analysis, DNA
1
1997
773
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1271
0.030
 Why?
Child, Preschool
3
2016
10373
0.030
 Why?
Patient Care Team
1
2019
600
0.030
 Why?
Incidence
1
2020
2619
0.030
 Why?
Congresses as Topic
1
2015
214
0.030
 Why?
Propylene Glycols
1
2013
25
0.030
 Why?
Ocular Physiological Phenomena
1
1992
9
0.030
 Why?
HLA-DR Antigens
1
2014
225
0.030
 Why?
Sphingosine
1
2013
36
0.030
 Why?
beta-Galactosidase
1
1992
75
0.030
 Why?
Quality-Adjusted Life Years
1
2013
108
0.030
 Why?
Markov Chains
1
2013
116
0.030
 Why?
Drug Therapy, Combination
1
2015
1009
0.030
 Why?
Mice, Inbred DBA
1
1992
182
0.030
 Why?
Leukocyte Count
1
1993
327
0.020
 Why?
Haplotypes
1
2014
471
0.020
 Why?
Mental Recall
1
2013
184
0.020
 Why?
Organ Specificity
1
1992
291
0.020
 Why?
Comparative Effectiveness Research
1
2013
151
0.020
 Why?
Mice
2
2023
16579
0.020
 Why?
Reference Values
1
2013
780
0.020
 Why?
Animals
3
2023
34501
0.020
 Why?
CD3 Complex
1
2012
101
0.020
 Why?
Ki-67 Antigen
1
2012
106
0.020
 Why?
Intestine, Small
1
1992
141
0.020
 Why?
Thymus Gland
1
1992
309
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
18
0.020
 Why?
Depression
2
2011
1289
0.020
 Why?
Patient Participation
1
2015
407
0.020
 Why?
Clinical Laboratory Techniques
1
2011
93
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1358
0.020
 Why?
Recombinant Fusion Proteins
1
1992
632
0.020
 Why?
Amino Acid Sequence
2
2004
2041
0.020
 Why?
Physical Endurance
1
2011
269
0.020
 Why?
Aged, 80 and over
2
2016
7040
0.020
 Why?
Acyclovir
1
2010
93
0.020
 Why?
Spinal Cord Neoplasms
1
1989
39
0.020
 Why?
Cell Count
1
2010
314
0.020
 Why?
History, 19th Century
1
2009
57
0.020
 Why?
Respiratory Function Tests
1
2011
582
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
54
0.020
 Why?
Pilot Projects
2
2004
1558
0.020
 Why?
Injections
1
2009
170
0.020
 Why?
History, 21st Century
1
2009
180
0.020
 Why?
Autoimmunity
1
2014
860
0.020
 Why?
Electrocardiography
1
2011
607
0.020
 Why?
History, 20th Century
1
2009
291
0.020
 Why?
Gene Expression
1
1992
1462
0.020
 Why?
Mice, Transgenic
1
1992
2069
0.020
 Why?
Age of Onset
1
2009
493
0.020
 Why?
Memory
1
2009
231
0.020
 Why?
Health
1
2007
74
0.020
 Why?
Walking
1
2011
494
0.020
 Why?
Association Learning
1
2007
61
0.020
 Why?
Prognosis
2
2006
3780
0.020
 Why?
Cerebral Ventricles
1
2006
48
0.020
 Why?
Herpesvirus 3, Human
1
2010
330
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
840
0.020
 Why?
Motor Skills
1
2007
90
0.020
 Why?
Hypothalamus
1
2006
144
0.020
 Why?
Phenotype
1
2014
3050
0.020
 Why?
Genetics
1
2005
25
0.020
 Why?
Immunologic Memory
1
2007
339
0.020
 Why?
Models, Theoretical
1
2009
546
0.020
 Why?
Hospitalization
1
2015
2071
0.020
 Why?
Social Support
1
2009
584
0.010
 Why?
Neurosciences
1
2005
29
0.010
 Why?
Syndecans
1
2004
4
0.010
 Why?
Internet
1
2009
618
0.010
 Why?
Clinical Protocols
1
2006
253
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
254
0.010
 Why?
Anisotropy
1
2004
70
0.010
 Why?
Immune System
1
2005
177
0.010
 Why?
Antiviral Agents
1
2010
704
0.010
 Why?
Plasma Cells
1
2004
65
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
13
0.010
 Why?
Videotape Recording
1
2003
34
0.010
 Why?
Infrared Rays
1
2003
21
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Saccades
1
2003
39
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
113
0.010
 Why?
Antilymphocyte Serum
1
2003
63
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
254
0.010
 Why?
Astrocytes
1
2005
189
0.010
 Why?
Whole-Body Irradiation
1
2003
75
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
126
0.010
 Why?
Feasibility Studies
1
2006
860
0.010
 Why?
Immunoglobulins
1
2003
157
0.010
 Why?
Observer Variation
1
2003
315
0.010
 Why?
Mice, Inbred C57BL
1
1992
5257
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2521
0.010
 Why?
Administration, Oral
1
2004
757
0.010
 Why?
Longitudinal Studies
1
2009
2697
0.010
 Why?
Sex Characteristics
1
2007
727
0.010
 Why?
Age Factors
1
2009
3117
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
5
0.010
 Why?
Consensus Sequence
1
2001
72
0.010
 Why?
Urinary Tract Infections
1
2003
150
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
937
0.010
 Why?
Cytomegalovirus Infections
1
2003
187
0.010
 Why?
Biopsy
1
2005
1085
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
20
0.010
 Why?
Infant
1
2015
8913
0.010
 Why?
Cohort Studies
1
2011
5369
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
86
0.010
 Why?
Predictive Value of Tests
1
2006
1936
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
70
0.010
 Why?
Acute Disease
1
2003
968
0.010
 Why?
Research
1
2003
409
0.010
 Why?
Combined Modality Therapy
1
2003
1209
0.010
 Why?
Lung
1
1992
3741
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1820
0.010
 Why?
Survival Rate
1
2003
1872
0.010
 Why?
Virus Replication
1
2001
444
0.010
 Why?
Monocytes
1
2001
541
0.010
 Why?
Models, Biological
1
2005
1693
0.010
 Why?
Binding Sites
1
2001
1239
0.010
 Why?
Case-Control Studies
1
2004
3326
0.010
 Why?
Aging
1
2007
1770
0.010
 Why?
Reproducibility of Results
1
2003
3023
0.010
 Why?
Transcription, Genetic
1
2001
1398
0.010
 Why?
DNA-Binding Proteins
1
2001
1415
0.010
 Why?
Cells, Cultured
1
2001
4008
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)